Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • China accounts for 66...

    China accounts for 66 percent of India's bulk drug imports in FY'17

    Written by Ruby Khatun Khatun Published On 2017-12-20T10:15:17+05:30  |  Updated On 17 Aug 2021 11:16 AM IST

    New Delhi: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 percent, Parliament was informed.


    In a written reply in Lok Sabha, Minister of State, Chemicals and Fertilisers Mansukh L Mandaviya said the other four major countries from where India imports bulk drugs are Germany, the US, Italy, and Singapore.

    India's import of active pharmaceutical ingredients (API) from China stood at Rs 12,254.97 crore in 2016-17, while that from the US was at Rs 820.18 crore.

    API import from Italy was at Rs 701.85 crore during the year under review, while the same from Germany and Singapore was at Rs 485.11 crore and Rs 422.01 crore respectively.

    "It may be mentioned that most of the imports of bulk drugs/API (are) being done in the country because of economic considerations," Mandaviya said.

    As India is a signatory to the WTO and TRIPs agreement, import restrictions have been removed, he added.

    In 2015-16, India's total bulk drug imports from the top five countries were at Rs 21,225.97 crore and it was Rs 19,833.19 crore in 2014-15, the minister added.

    Replying to another query, Mandaviya said the Department of Pharmaceuticals has asked medical device associations, healthcare industry bodies and relevant regulatory agencies to help in categorising medical devices.

    The purpose is to categorise medical devices so as to have different trade margins for various categories for different segments, considering the vast diversity and the logistics required in delivering them to patients, he said.

    "Industry has proposed that the total trade margins for medical devices could be capped to make quality medical devices affordable. Discussions on the issue with industry resulted in the need for categorisation," Mandaviya said, adding there has been no consensus on the issue.
    66 percentaccountsactive pharmaceutical ingredientsagreementAPIbulk drug importsbulk drugschinaDepartment of PharmaceuticalsGermanyIndiaIndia's bulk drug importsItalyLok SabhaMansukh L Mandaviyamedical device associationsMedical DevicesParliamentSingaporeTRIPsWTO
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok